Oncology Information Systems Market by Product and Geography - Forecast and Analysis 2022-2026

The oncology information systems (OIS) market share is expected to increase by USD 1.27 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.38%.

This oncology information systems market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers oncology information systems market segmentation by product (software and services) and geography (North America, APAC, Europe, South America, and MEA). The oncology information systems market report also offers information on several market vendors, including Accuray Inc., Cerner Corp., CureMD.com Inc., Elekta AB, F. Hoffmann-La Roche Ltd., General Electric Co., International Business Machines Corp., Koninklijke Philips NV, McKesson Corp., and Siemens AG among others.

What will the Oncology Information Systems Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Oncology Information Systems Market Size for the Forecast Period and Other Important Statistics

Oncology Information Systems Market: Key Drivers and Challenges

The increasing prevalence of cancer is notably driving the OIS market growth, although factors such as rising medical data privacy concerns may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the oncology information systems industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Oncology Information Systems Market Driver

One of the key factors driving growth in the oncology information systems market is the increasing prevalence of cancer. Cancer is one of the leading causes of death worldwide. Lung, liver, stomach, colorectal, breast, and esophageal cancers are the most common cancers prevalent worldwide. Changes in lifestyle, unhealthy diets, smoking, fewer pregnancies, and longtime exposure to UV rays are expected to increase the prevalence of cancers that are associated with these factors, such as breast cancer, lung cancer, and colorectal cancer. Most cancers that reach the chronic stages cannot be treated with conventional drugs. This is expected to increase the demand for interventional oncology procedures, such as tissue ablation and embolization, thereby driving the growth of the global OIS market.

Key Oncology Information Systems Market Challenge

The rising medical data privacy concerns will be a major challenge for the oncology information systems market during the forecast period. The increasing adoption of advanced technologies for storing, processing, analyzing, and interpreting medical documents is giving rise to data privacy concerns. Personal data, medical and healthcare records, and the medication information of any person should not be disclosed without authorization and permissions as per the different privacy acts implemented in various countries. Despite the presence of different legislative acts, data privacy concerns will continue to rise due to the increased use of advanced technologies and the outsourcing of medical document processing. These drawbacks may be because of improper data authentication, system authentication, unsecured resources, and other money-related data breach risks.

This oncology information systems market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Oncology Information Systems Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Accuray Inc.
• Cerner Corp.
• CureMD.com Inc.
• Elekta AB
• F. Hoffmann-La Roche Ltd.
• General Electric Co.
• International Business Machines Corp.
• Koninklijke Philips NV
• McKesson Corp.
• Siemens AG

This statistical study of the oncology information systems market encompasses successful business strategies deployed by the key vendors. The OIS market is fragmented and the vendors are deploying growth strategies such as forming strategic partnerships to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The oncology information systems market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Oncology Information Systems Market?

For more insights on the market share of various regions Request for a FREE sample now!

41% of the market's growth will originate from North America during the forecast period. The US is the key market for oncology information systems in North America. Market growth in North America will be faster than the growth of the market in other regions.

The presence of many oncology-related pharmaceutical companies and advanced healthcare infrastructure in countries such as the US and Canada will facilitate the oncology information systems market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Product Segments in the Oncology Information Systems Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The oncology information systems market share growth by the software segment will be significant during the forecast period. The software segment will grow significantly, owing to the increasing popularity and use of mobile devices and their rising capabilities are prompting healthcare providers to invest substantially in the development of mobile and application-based solutions. The transition from on-premises deployment solutions to the cloud-based deployment model is driving increased investments in cloud-based oncology information systems software. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the OIS market size and actionable market insights on post COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Oncology Information Systems Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive oncology information systems market growth during the next five years
• Precise estimation of the oncology information systems market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the OIS industry across North America, APAC, Europe, South America, and MEA
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of OIS market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch